Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Assets Average (2020 - 2025)

Historic Assets Average for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $114.5 million.

  • Pulse Biosciences' Assets Average rose 7158.1% to $114.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.5 million, marking a year-over-year increase of 7158.1%. This contributed to the annual value of $95.8 million for FY2024, which is 3983.26% up from last year.
  • Latest data reveals that Pulse Biosciences reported Assets Average of $114.5 million as of Q3 2025, which was up 7158.1% from $126.8 million recorded in Q2 2025.
  • Over the past 5 years, Pulse Biosciences' Assets Average peaked at $132.9 million during Q1 2025, and registered a low of $40.1 million during Q2 2022.
  • Over the past 5 years, Pulse Biosciences' median Assets Average value was $70.4 million (recorded in 2023), while the average stood at $76.1 million.
  • In the last 5 years, Pulse Biosciences' Assets Average crashed by 5010.4% in 2022 and then soared by 18309.89% in 2025.
  • Over the past 5 years, Pulse Biosciences' Assets Average (Quarter) stood at $63.2 million in 2021, then surged by 30.99% to $82.7 million in 2022, then decreased by 24.39% to $62.5 million in 2023, then surged by 80.26% to $112.8 million in 2024, then increased by 1.56% to $114.5 million in 2025.
  • Its Assets Average stands at $114.5 million for Q3 2025, versus $126.8 million for Q2 2025 and $132.9 million for Q1 2025.